# Parkwalk's Biotech Investments: 24 Startups in Its Portfolio (2026) > The 24 Biotech startups Parkwalk has backed, by stage: $438M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/parkwalk-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 8 - [*I* Immutrin](https://millionrounds.com/company/immutrin) - [*M* Mogrify](https://millionrounds.com/company/mogrify) - [Fluidic Analytics](https://millionrounds.com/company/fluidic-analytics) - [Xampla](https://millionrounds.com/company/xampla) - [Oxford Endovascular](https://millionrounds.com/company/oxford-endovascular) - [Abselion](https://millionrounds.com/company/abselion) - [CamGene Therapeutics](https://millionrounds.com/company/camgene-therapeutics) - [Enhanc3D Genomics](https://millionrounds.com/company/enhanc3d-genomics) ## Stage not reported 6 - [DIOSynVax](https://millionrounds.com/company/diosynvax) - [Istesso](https://millionrounds.com/company/istesso) - [Carbometrics](https://millionrounds.com/company/carbometrics) - [Semarion](https://millionrounds.com/company/semarion) - [Zentraxa](https://millionrounds.com/company/zentraxa) - [pixlbio](https://millionrounds.com/company/pixlbio) ## Pre-seed and seed 6 - [Scripta Therapeutics](https://millionrounds.com/company/scripta-therapeutics) - [Ikarovec](https://millionrounds.com/company/ikarovec) - [Qkine](https://millionrounds.com/company/qkine) - [PharmEnable](https://millionrounds.com/company/pharmenable) - [Evoralis](https://millionrounds.com/company/evoralis) - [NK:IO](https://millionrounds.com/company/nk-io) ## Series B 4 - [PetMedix](https://millionrounds.com/company/petmedix) - [Congenica](https://millionrounds.com/company/congenica) - [Sphere Fluidics](https://millionrounds.com/company/sphere-fluidics) - [*O* Oxyntix](https://millionrounds.com/company/oxyntix) ## Segment by segment ### Series A 8 startups · $229M raised - [*I* **Immutrin**](https://millionrounds.com/company/immutrin) Immutrin is a biotech developing next‐generation antibody therapies to clear amyloid deposits and reverse amyloidosis. United Kingdom $87M - [*M* **Mogrify**](https://millionrounds.com/company/mogrify) United Kingdom $50M - [**Fluidic Analytics**](https://millionrounds.com/company/fluidic-analytics) Fluidic Analytics is a biotechnology research company founded in 2013 as a spinout from the University of Cambridge. United Kingdom $28M - [**Xampla**](https://millionrounds.com/company/xampla) Xampla is a materials innovation company based in Cambridge, UK, founded in 2018 as a spin-out from the University of Cambridge. United Kingdom $23M - [**Oxford Endovascular**](https://millionrounds.com/company/oxford-endovascular) Oxford Endovascular are developing a novel treatment for treating brain aneurysms. United Kingdom $21M - [**Abselion**](https://millionrounds.com/company/abselion) Abselion is a life science tools company based in Cambridge, UK, focused on developing measurement technologies for biomolecule analysis. United Kingdom $8.4M - [**CamGene Therapeutics**](https://millionrounds.com/company/camgene-therapeutics) CamGene Therapeutics is a biotechnology company based in Cambridge, UK, focused on developing RNA-based gene medicines specificall United Kingdom $5.4M - [**Enhanc3D Genomics**](https://millionrounds.com/company/enhanc3d-genomics) Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease. United Kingdom $5.4M ### Stage not reported 6 startups · $97M raised - [**DIOSynVax**](https://millionrounds.com/company/diosynvax) DIOSynVax is a clinical-stage biotechnology company based in Cambridge, UK, focused on developing next-generation vaccines using a United Kingdom $44M - [**Istesso**](https://millionrounds.com/company/istesso) Istesso is a London-based biopharmaceutical company focused on immunometabolism drug discovery and development. United Kingdom $29M - [**Carbometrics**](https://millionrounds.com/company/carbometrics) Carbometrics Ltd. United Kingdom $14M - [**Semarion**](https://millionrounds.com/company/semarion) Semarion is a University of Cambridge spin-out company founded in 2018, focused on accelerating *in vitro* drug discovery. United Kingdom $9.3M - [**Zentraxa**](https://millionrounds.com/company/zentraxa) Zentraxa Limited is a biotechnology and engineering biology company based in Bristol, England. United Kingdom $386K - [**pixlbio**](https://millionrounds.com/company/pixlbio) pixlbio is a biotechnology company focused on predictive biology for drug discovery and safety assessment. United Kingdom $136K ### Pre-seed and seed 6 startups · $45M raised - [**Scripta Therapeutics**](https://millionrounds.com/company/scripta-therapeutics) Scripta Therapeutics operates as a bio-tech company. United Kingdom $12M - [**Ikarovec**](https://millionrounds.com/company/ikarovec) Ikarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseas United Kingdom $10M - [**Qkine**](https://millionrounds.com/company/qkine) Qkine is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. United Kingdom $9.9M - [**PharmEnable**](https://millionrounds.com/company/pharmenable) PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery. United Kingdom $7.5M - [**Evoralis**](https://millionrounds.com/company/evoralis) Evoralis Limited is a biotechnology company based in Cambridge, United Kingdom, founded in May 2021. United Kingdom $4.2M - [**NK:IO**](https://millionrounds.com/company/nk-io) NK:IO is a London-based biotech company and a spinout from Imperial College London, focused on developing innovative therapies for United Kingdom $1.5M ### Series B 4 startups · $66M raised - [**PetMedix**](https://millionrounds.com/company/petmedix) PetMedix is a pet therapeutics startup. United Kingdom $37M - [**Congenica**](https://millionrounds.com/company/congenica) Congenica is a biotechnology company that provides a diagnostic decision support platform. United Kingdom $15M - [**Sphere Fluidics**](https://millionrounds.com/company/sphere-fluidics) Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services. United Kingdom $12M - [*O* **Oxyntix**](https://millionrounds.com/company/oxyntix) Oxyntix is a research-intensive team, developing and commercialising new technologies in energy and process engineering, among other fields. United Kingdom $2.6M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Parkwalk as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Parkwalk portfolio map** 82 startups · $2.0B](https://millionrounds.com/portfolio-maps/parkwalk-portfolio-map)[Co-investors **Who invests with Parkwalk** 34 co-investors](https://millionrounds.com/portfolio-maps/parkwalk-co-investors)[Sector portfolio **Antler's AI portfolio** 168 startups · $3.8B](https://millionrounds.com/portfolio-maps/antler-ai-portfolio)[Sector portfolio **Index Ventures' AI portfolio** 126 startups · $49B](https://millionrounds.com/portfolio-maps/index-ventures-ai-portfolio)[Sector portfolio **Innovate UK's Biotech portfolio** 88 startups · $1.7B](https://millionrounds.com/portfolio-maps/innovate-uk-biotech-portfolio)[Sector portfolio **GSR's Web3 & Crypto portfolio** 77 startups · $4.2B](https://millionrounds.com/portfolio-maps/gsr-web3-crypto-portfolio) ## Raising from investors like Parkwalk? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)